Clinical trial
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
NCT03073603 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 20, 2017
- Completion date
- August 31, 2021
- Enrollment
- 259 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.